Hyperfibrinolysis in a case of myelodysplastic syndrome with leukemic spread of mast cells
Authors:
Open Access
- 27 April 1999
- journal article
- case report
- Published by Wiley in American Journal of Hematology
- Vol. 61 (1) , 66-77
Abstract
Mast cells (MC) are multipotent hemopoietic effector cells producing diverse mediators like histamine, heparin, or tissue type plasminogen activator. We report a 75‐year‐old male patient with myelodysplastic syndrome (MDS) of recent onset (3 months' history) associated with a massive leukemic spread of immature tryptase+ MC (tentative term: myelomastocytic leukemia). The patient presented with pancytopenia, bleeding, hypofibrinogenemia, and an increased cellular tryptase level. Moreover, an excessive elevation of plasmin‐antiplasmin complexes (9,200 ng/ml; normal range: 10–150), an elevated D‐dimer, and an increase in thrombin‐antithrombin III complexes were found. The identity of the circulating MC was confirmed by immunophenotyping (CD117/c‐kit+, CD123/IL‐3Rα−, CD11b/C3biR−), biochemical analysis (cellular ratio [ng:ng] of tryptase to histamine >1), and electron microscopy. Bone marrow (bm) examination showed trilineage dysplasia (17% blasts), 30% diffusely scattered MC, and a complex karyotype. No dense, compact MC infiltrates (mastocytosis) were detectable in bm sections. Despite hyperfibrinolysis and mediator syndrome (flushing, headache), the patient received remission induction polychemotherapy (DAV) followed by two cycles of consolidation with intermediate dose ARA‐C (2 × 1 g/m2/day on days 1, 3, and 5). He entered complete remission after the first chemotherapy cycle without evidence of recurring MDS. Moreover, in response to chemotherapy, the hyperfibrinolysis and mediator syndrome resolved, and the circulating c‐kit+ MC disappeared. We suggest consideration of polychemotherapy as a therapeutic option in patients with high‐risk MDS of recent onset, even in the case of MC lineage involvement. Am. J. Hematol. 61:66–77, 1999.Keywords
This publication has 48 references indexed in Scilit:
- Identification of a Committed Precursor for the Mast Cell LineageScience, 1996
- dic(9; 20): A new recurrent chromosome abnormality in adult acute lymphoblastic leukemiaGenes, Chromosomes and Cancer, 1995
- The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia: Proposals by the French ‐ American ‐ British Cooperative Leukaemia GroupBritish Journal of Haematology, 1994
- The riddle of the mast cell: kit(CD117)-ligand as the missing link?Immunology Today, 1994
- Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.Journal of Clinical Investigation, 1993
- Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections.Journal of Histochemistry & Cytochemistry, 1991
- Procedural guide to specimen handling for the ultrastructural pathology service laboratoryJournal of Electron Microscopy Technique, 1987
- Mast Cell Leukemia: Report of a Case and Review of the LiteratureMayo Clinic Proceedings, 1986
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981
- An International System for Human Cytogenetic Nomenclature — High-Resolution Banding (1981): ISCN (1981)Cytogenetic and Genome Research, 1981